A new vaccine against advanced cutaneous melanoma will be available to UK patients through an NHS program
Sanziana Georgescu
Health
sursa foto: pexels.com
Always see our news on Google
<p>The UK's National Health Service is launching an innovative vaccine, iSCICIB1+, for patients with advanced cutaneous melanoma to improve the immune system's response to immunotherapy treatments. The program, part of the Cancer Vaccine Launch Pad, will enable rapid access to clinical trials, targeting 10,000 patients by 2030. The first patients are expected to start treatment next month, and the initiative highlights the potential of vaccines to transform cancer care and save lives. Melanoma is the fifth most common cancer in the UK and early monitoring is essential for effective treatment.
Sources
Latest News
11:54
Reinforcement and modernization works at the Bulandra Theatre Building, with an investment of 98.6 million lei
11:53
The United States Army has consumed almost 80% of the THAAD interceptors and half of the Patriot missiles in the conflict with Iran.
11:49
The US Embassy in Romania has appointed David Galbraith as Deputy Chief of Mission.
11:35
Two incidents occurred during the military flight exercises in the area of the airfield in Buzău
11:25
Dragoș Pîslaru accuses PSD and AUR of putting the money from PNRR at risk after the Senate vote on decarbonization: "It's an absolute blockage, requested by no one, made for a populist issue."
See more news
NEWS ON THE SAME TOPICS
.webp)
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
